Repricings, div recaps no sweat for levloans, but no flood expected

Aggressive-looking leveraged loan deals for BSN Medical and RAC looked set for success this week as the lack of loan paper weighs on investors. But although bankers expect more companies to try repricings and dividend recaps, they do not see a wave of similar deals coming to market simply because there are not enough credits that are willing and able to carry out such transactions.

  • 12 Oct 2012

German bandage maker BSN Medical is ready to allocate its repriced loans on Friday, while patent management group CPA Global becomes the second European company this month to attempt to reduce its borrowing costs.

UK car breakdown firm RAC’s loan was described as "virtually a done deal" by bankers ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 BNP Paribas 10,542 20 17.55
2 Bank of America Merrill Lynch (BAML) 6,103 21 10.16
3 Citi 5,130 13 8.54
4 JP Morgan 4,681 6 7.79
5 Morgan Stanley 4,137 11 6.89

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 81,261.11 236 11.54%
2 Bank of America Merrill Lynch 66,433.81 187 9.43%
3 Wells Fargo Securities 57,637.40 170 8.18%
4 JPMorgan 53,570.42 158 7.61%
5 Credit Suisse 45,349.30 117 6.44%